Clinical Trial Update: A Study of SKLB1028 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

This is a Phase 1 trial evaluating SKLB1028 in subjects with relapsed or refractory acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• SKLB1028

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: UNKNOWN